These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10052536)

  • 1. Methadone is poorly removed by haemodialysis.
    Furlan V; Hafi A; Dessalles MC; Bouchez J; Charpentier B; Taburet AM
    Nephrol Dial Transplant; 1999 Jan; 14(1):254-5. PubMed ID: 10052536
    [No Abstract]   [Full Text] [Related]  

  • 2. Replacement of (R)-methadone by a double dose of (R,S)-methadone in addicts: interindividual variability of the (R)/(S) ratios and evidence of adaptive changes in methadone pharmacokinetics.
    Eap CB; Finkbeiner T; Gastpar M; Scherbaum N; Powell K; Baumann P
    Eur J Clin Pharmacol; 1996; 50(5):385-9. PubMed ID: 8839661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical use of methadone.
    Layson-Wolf C; Goode JV; Small RE
    J Pain Palliat Care Pharmacother; 2002; 16(1):29-59. PubMed ID: 14650449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of methadone.
    Lugo RA; Satterfield KL; Kern SE
    J Pain Palliat Care Pharmacother; 2005; 19(4):13-24. PubMed ID: 16431829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradialytic clearance of opioids: methadone versus hydromorphone.
    Perlman R; Giladi H; Brecht K; Ware MA; Hebert TE; Joseph L; Shir Y
    Pain; 2013 Dec; 154(12):2794-2800. PubMed ID: 23973378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective pharmacokinetics of methadone in chronic pain patients.
    Kristensen K; Blemmer T; Angelo HR; Christrup LL; Drenck NE; Rasmussen SN; Sjøgren P
    Ther Drug Monit; 1996 Jun; 18(3):221-7. PubMed ID: 8738759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain management in chronic kidney disease: the pharmacokinetics and pharmacodynamics of hydromorphone and hydromorphone-3-glucuronide in hemodialysis patients.
    Davison SN; Mayo PR
    J Opioid Manag; 2008; 4(6):335-6, 339-44. PubMed ID: 19192761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone-substitution and driving ability.
    Rössler H; Battista HJ; Deisenhammer F; Günther V; Pohl P; Prokop L; Riemer Y
    Forensic Sci Int; 1993 Nov; 62(1-2):63-6. PubMed ID: 8300036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced methadone clearance during aromatase inhibition.
    Lu WJ; Thong N; Flockhart DA
    J Clin Psychopharmacol; 2012 Aug; 32(4):511-7. PubMed ID: 22722506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slow metabolism and long half life of methadone in a patient with lung cancer and cirrhosis.
    Beauverie P; Furlan V; Edel YA
    Ann Med Interne (Paris); 2001 Nov; 152 Suppl 7():50-2. PubMed ID: 11965098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PXR polymorphisms interacted with CYP2B6 polymorphisms on methadone metabolites.
    Tsai HJ; Wang SC; Tian JN; Chang TK; Ho IK; Hsiao CF; Chen CH; Tan HK; Lin L; Wu CS; Su LW; Huang CL; Yang YH; Liu ML; Lin KM; Liu YL
    J Clin Psychopharmacol; 2013 Feb; 33(1):137-40. PubMed ID: 23288240
    [No Abstract]   [Full Text] [Related]  

  • 12. Absence of opioid withdrawal symptoms in patients receiving methadone and the protease inhibitor lopinavir-ritonavir.
    Clarke S; Mulcahy F; Bergin C; Reynolds H; Boyle N; Barry M; Back DJ
    Clin Infect Dis; 2002 Apr; 34(8):1143-5. PubMed ID: 11915005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methadone maintenance therapy and chronic pain.
    Streltzer J; Kosten TR
    JAMA; 2003 Nov; 290(18):2403; author reply 2403-4. PubMed ID: 14612466
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacokinetic interactions between methadone and antiretroviral medication in HIV positive patients].
    Pérez Pons JC; Jornet Montaña S; Bonet Esteve A
    Med Clin (Barc); 2002 Jul; 119(6):224-9. PubMed ID: 12200011
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid measurement of plasma methadone in a clinical setting using florescence polarization immunoassay.
    Kell MJ; Techman T
    J Addict Dis; 1996; 15(2):69-83. PubMed ID: 8704002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone in healthy goats - pharmacokinetics, behaviour and blood pressure.
    Olsén L; Olsson K; Hydbring-Sandberg E; Bondesson U; Ingvast-Larsson C
    Res Vet Sci; 2013 Aug; 95(1):231-7. PubMed ID: 23540608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methadone, morphine and PTSD.
    Macleod AD; Duffy SG
    Aust N Z J Psychiatry; 2002 Dec; 36(6):816-7. PubMed ID: 12406127
    [No Abstract]   [Full Text] [Related]  

  • 18. Methadone: a double edged sword.
    Lipman AG
    J Pain Palliat Care Pharmacother; 2005; 19(4):3-4. PubMed ID: 16431826
    [No Abstract]   [Full Text] [Related]  

  • 19. Diclofenac does not modify methadone bioavailability in cancer patients.
    Bianchi M; Clavenna A; Groff L; Zecca E; Ripamonti C
    J Pain Symptom Manage; 1999 Apr; 17(4):227-9. PubMed ID: 10203873
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioavailability and pharmacokinetics of oral and injectable formulations of methadone after intravenous, oral, and intragastric administration in horses.
    Linardi RL; Stokes AM; Keowen ML; Barker SA; Hosgood GL; Short CR
    Am J Vet Res; 2012 Feb; 73(2):290-5. PubMed ID: 22280392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.